Involvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• Lipedema is a chronic condition primarily affecting women, characterized by adipose tissue dysfunction.
• Its etiology is largely unknown, but recent studies suggest macrophage involvement and altered polarization in affected tissues.
• The macrophage migration inhibitory factor (MIF) family is implicated in macrophage accumulation and polarization, and influences adipose tissue inflammation.

Purpose of the Study:

• To investigate the expression of macrophage migration inhibitory factor-1 (MIF-1), MIF-2, and their common receptor CD74 in lipedema adipose tissue.
• To explore the potential role of the MIF family in the pathophysiology of lipedema.

Main Methods:

• Quantitative real-time PCR (qPCR) was used to analyze mRNA expression levels of MIF-1, MIF-2, and CD74.
• Immunohistochemistry (IHC) was employed to validate CD74 expression at the cellular level.
• Tissue samples from 11 lipedema patients and 11 matched controls were analyzed.

Main Results:

• mRNA expression of MIF-1 was significantly elevated in lipedema patients compared to controls (p=0.0485).
• mRNA expression of CD74 was also significantly higher in lipedema patients (p=0.0097).
• MIF-2 expression showed no significant difference between lipedema and control groups (p=0.9718). IHC confirmed increased CD74 expression in lipedema tissues.

Conclusions:

• These findings provide the first evidence suggesting the involvement of the MIF family in lipedema.
• The MIF-1-CD74 axis is a potential pathway implicated in the development or progression of lipedema.
• Further research is warranted to elucidate the precise role of MIF-1 and CD74 in lipedema pathophysiology.